24.11.2016 • NewsElaine BurridgePPSABIC

SABIC Builds PP Pilot Plant

Saudi Arabian chemicals giant SABIC will start up a new pilot plant for developing next-generation polypropylene (PP) grades by the end of March 2017. The plant is the latest in a series of investments SABIC is making at the Brightlands Chemelot R&D and manufacturing campus in Sittard-Geleen, the Netherlands. The company opened a new research facility at the site in May of this year.

“When it starts up next year, we will have considerably more capacity to develop new PP materials for commercialization in our current European assets in Geleen and in Gelsenkirchen, Germany,” said Lina Prada, SABIC’s global PP technology director. Work has been contracted to Dutch company Zeton, which has developed a skid-mounted system that allows faster implementation and flexibility of design. Zeon will first build and test the plant in Enschede, the Netherlands, before partially dismantling it and delivering it to Geleen for installation next month.

The facility, which will use gas-phase polymerization technology, will support the production of superior materials at nearby full-scale plants that meet the needs of different industries such as automotive, pipe, appliances and advanced packaging. SABIC said it is looking in particular to develop grades with improved stiffness/impact, flow properties and other specific secondary properties. The group will concentrate on developing impact grades as well as random copolymers and hompolymers. Experiments will also be performed on advanced catalysts.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.